TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2008

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.

Catherine Sebban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.